Jul 17, 2015 8:00am EDT Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN
Apr 13, 2015 11:00am EDT Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes
Apr 09, 2015 11:00am EDT Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
Mar 09, 2015 10:00am EDT Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP Manufacturing Facility and Business Unit From Alkermes